โ† All MTM Flashcard Decks

Polypharmacy Assessment & Reduction Flashcards

7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 7 Polypharmacy Assessment & Reduction flashcards as text
  1. A patient takes warfarin and is started on fluconazole for a fungal infection. During an MTM follow-up, the INR rises from 2.4 to 4.8. This is BEST classified as which type of drug-drug interaction?

    Answer: Pharmacokinetic interaction via CYP2C9 inhibition

    Fluconazole inhibits CYP2C9, the primary enzyme responsible for warfarin (S-enantiomer) metabolism, leading to elevated warfarin levels and increased anticoagulation.

  2. When using the Medication Appropriateness Index (MAI) during polypharmacy assessment, how many criteria does the tool evaluate for each medication?

    Answer: 10

    The MAI evaluates 10 criteria for each medication including indication, effectiveness, dosage, directions, drug interactions, and cost.

  3. A 72-year-old patient with hypertension, heart failure, and CKD stage 3 is taking lisinopril 40 mg, spironolactone 25 mg, and potassium chloride supplements. Which concern should the pharmacist prioritize?

    Answer: Hyperkalemia risk from concurrent use of multiple potassium-retaining agents

    Concurrent use of an ACE inhibitor, aldosterone antagonist, and potassium supplement significantly increases the risk of life-threatening hyperkalemia.

  4. Which principle guides the deprescribing process in polypharmacy management?

    Answer: Tapering or discontinuing one medication at a time to monitor for withdrawal or disease recurrence

    Discontinuing one medication at a time allows for monitoring of withdrawal effects and disease recurrence attributable to each specific medication.

  5. A pharmacist conducting an MTM session identifies that a patient takes aspirin 81 mg for primary prevention. Per current evidence, what is the MOST appropriate recommendation for a 76-year-old patient with no prior cardiovascular events?

    Answer: Recommend deprescribing aspirin as benefits no longer outweigh bleeding risks in primary prevention for this age group

    Current guidelines recommend against initiating or continuing aspirin for primary prevention in adults over 60 due to increased bleeding risk outweighing cardiovascular benefits.

  6. Which patient-centered technique is MOST effective when discussing medication reduction with a patient who is resistant to deprescribing?

    Answer: Motivational interviewing to explore the patient's concerns and goals

    Motivational interviewing helps elicit the patient's own motivation for change by exploring ambivalence and aligning medication decisions with personal health goals.

  7. During reconciliation, a pharmacist discovers a patient takes both sertraline and tramadol. Which serious drug interaction is of GREATEST concern?

    Answer: Serotonin syndrome

    Concurrent use of sertraline (SSRI) and tramadol (serotonin reuptake inhibitor and weak opioid) significantly increases the risk of serotonin syndrome.